Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Classen Immunotherapies, Inc. v. GalaxoSmithKline et al
Case Number:
1:04-cv-02607
Court:
Nature of Suit:
Judge:
Firms
- Covington & Burling
- Foley Hoag
- Kramon & Graham
- Morris Nichols
- Saul Ewing
- Thompson Hine
- Venable LLP
- WilmerHale
Companies
Sectors & Industries:
-
May 15, 2014
Biogen Gets Attys' Fees In Classen Immunization IP Row
A Maryland federal judge on Wednesday found that Classen Immunotherapies Inc.'s claims that Biogen Idec Inc. infringed its patents for evaluating a vaccine immunization schedule were objectively baseless, dismissing Biogen from the case and granting its request for attorneys' fees.
-
August 09, 2012
GSK Can't Use Prometheus To Nix Classen's Patent Suit
A Maryland federal judge on Thursday told GlaxoSmithKline PLC that it couldn't use the U.S. Supreme Court's recent Prometheus decision to dismiss Classen Immunotherapies Inc.'s lawsuit alleging the pharmaceutical giant infringed a patented infant immunization process.
-
May 30, 2012
GSK Can't Escape Classen's Patent Infringement Suit
A Maryland federal judge on Tuesday refused to dismiss the bulk of a case against GlaxoSmithKline PLC alleging the pharmaceutical giant infringed Classen Immunotherapies Inc.'s patents for evaluating a vaccine immunization schedule, while tossing contributory and willful infringement claims.